Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Mayo Clinic
Eli Lilly and Company
Stanford University
Black Diamond Therapeutics, Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
Tempus AI
Fundación GECP
Ohio State University Comprehensive Cancer Center
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute